CureVac’s COVID-19 vaccine begins rolling review with EMA

15th February 2021 Uncategorised 0

CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial

More: CureVac’s COVID-19 vaccine begins rolling review with EMA
Source: News